A Case Series of NSCLC Patients with Different Molecular Characteristics and Choroidal Metastases: Improvement in Vision withTreatment Including Pemetrexed and Bevacizumab

Lignende værker

• A Patient with Anaplastic Lymphoma Kinase (ALK) FISH Positive NSCLC with Development of Leptomeningeal Carcinomatosis while on Targeted Treatment with Crizotinib
  af: Riess, Jonathan W., et al.
  Udgivet: (2013)
• Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases
  af: Tian, Yaru, et al.
  Udgivet: (2019)
• Anti-angiogenic agents in Non-Small-Cell Lung Cancer (NSCLC): a perspective on the MONET1 (Motesanib NSCLC Efficacy and Tolerability) study
  af: Das, Millie, et al.
  Udgivet: (2012)
• Angiogenesis and lung cancer: ramucirumab prolongs survival in 2(nd)-line metastatic NSCLC
  af: Das, Millie, et al.
  Udgivet: (2014)
• A Case Series of Lengthy Progression-Free Survival With Pemetrexed-Containing Therapy in Metastatic Non–Small-Cell Lung Cancer Patients Harboring ROS1 Gene Rearrangements
  af: Riess, Jonathan W., et al.
  Udgivet: (2013)